<--- Back to Details
First PageDocument Content
Hepatitis / Non-alcoholic fatty liver disease / Steatohepatitis / Fatty liver / Metformin / Cirrhosis / Insulin resistance / Chronic liver disease / Liver biopsy / Medicine / Health / Hepatology
Date: 2014-05-29 13:51:55
Hepatitis
Non-alcoholic fatty liver disease
Steatohepatitis
Fatty liver
Metformin
Cirrhosis
Insulin resistance
Chronic liver disease
Liver biopsy
Medicine
Health
Hepatology

Microsoft PowerPoint - Kohli - NASH.pptx

Add to Reading List

Source URL: www.naspghan.org

Download Document from Source Website

File Size: 718,31 KB

Share Document on Facebook

Similar Documents

CLIF Consortium Protocol of the CLIF Acute-oN-ChrONic LIver Failure in Cirrhosis (CANONIC) Core Study Case Report Form

DocID: 1v63p - View Document

Evaluation and Management of the Surgical Patient with Cirrhosis: Understanding and Justifying the Risk Dr. Eternity D. Labio FPCP FPSG FPSDE

DocID: 1uVgT - View Document

INFECTIOUS COMPLICATIONS IN PATIENTS WITH CIRRHOSIS: WHAT SHALL WE DO? Jenny Lim Limquiaco, MD

DocID: 1uMjX - View Document

COMMENTARY High fructose corn syrup (HFCS) plays a dominant role in the pathogenesis of NAFLD-associated cirrhosis Selin Sahin MD, Metin Basaranoglu MD

DocID: 1uioY - View Document

日本消化器病学会 肝硬変診療ガイドライン 2015(改訂第 2 版) Evidence-based Clinical Practice Guidelines for Liver Cirrhosis 2015(2nd Edition) 日本消化器病学会肝硬変診療ガイド

DocID: 1t4b3 - View Document